Oxford RECOVERY Evaluation of COVID-19 Therapy Flawed Against Hydroxychloroquine and Dangerous to Patients
Note: this article is dated March 28, just days after the RECOVERY trial was announced. See linked below the follow up to this article, dated
Note: this article is dated March 28, just days after the RECOVERY trial was announced. See linked below the follow up to this article, dated
The extremely poorly researched article stresses the need for further research. “Chloroquine seems to block the coronavirus in lab studies. There’s some anecdotal evidence from
According to the website of the “Randomised Evaluation of Covid-19 Therapy” project, there are 4 treatments being tested. See website excerpt below And see critique
According to the Associated Press, British Prime Minister Boris Johnson has tested positive for the new coronavirus, the first leader of a major nation to
See Press Release by UK Government dated March 25 Chloroquine and Hydroxychloroquine not licensed for coronavirus (COVID-19) treatment Recent media reports have suggested that chloroquine
See here an analysis of the similar UK protocol: http://covexit.com/oxford-recovery-evaluation-of-covid-19-therapy-flawed-against-hydroxychloroquine-and-dangerous-to-patients/ See Media Release: A European clinical trial to evaluate four experimental treatments for COVID-19 starts today.